Dihydroisotanshinone I

CAS No. 20958-18-3

Dihydroisotanshinone I( ——— )

Catalog No. M38002 CAS No. 20958-18-3

Dihydroisotanshinone I

Purity : >98% (HPLC)

COA Datasheet HNMR HPLC MSDS Handing Instructions
Size Price / USD Stock Quantity
25MG Get Quote Get Quote
50MG Get Quote Get Quote
100MG Get Quote Get Quote
200MG Get Quote Get Quote
500MG Get Quote Get Quote
1G Get Quote Get Quote

Biological Information

  • Product Name
    Dihydroisotanshinone I
  • Note
    Research use only, not for human use.
  • Brief Description
    Dihydroisotanshinone I
  • Description
    Dihydroisotanshinone I
  • In Vitro
    ———
  • In Vivo
    ———
  • Synonyms
    ———
  • Pathway
    Others
  • Target
    Other Targets
  • Recptor
    ———
  • Research Area
    ———
  • Indication
    ———

Chemical Information

  • CAS Number
    20958-18-3
  • Formula Weight
    278.307
  • Molecular Formula
    C18H14O3
  • Purity
    >98% (HPLC)
  • Solubility
    ———
  • SMILES
    ———
  • Chemical Name
    ——

Shipping & Storage Information

  • Storage
    (-20℃)
  • Shipping
    With Ice Pack
  • Stability
    ≥ 2 years

Reference

1. Ying Bai, et al. Development of novel celastrol-ligustrazine hybrids as potent peroxiredoxin 1 inhibitors against lung cancer. Eur J Med Chem. 2023, 259, 115656.
molnova catalog
related products
  • Bisphenoxyethanolflu...

    Bisphenoxyethanolfluorene a high stability of the new type of organic chemical raw materials, mainly used for synthesis of heat resistance, excellent transparency and high refractive index of polymer monomer.

  • Fibrinopeptide A, hu...

    Fibrinopeptide A, human is a 16-residue short polypeptide cleaved from fibrinogen by thrombin. Fibrinopeptide A (FPA) is produced from the N-terminal Aα region of fibrinogen protein, on cleavage by thrombin.

  • Maltotriose

    Maltotriose is a common oligosaccharide metabolite found in human urine after maltose ingestion or infusion. Maltotriose is increased in Glycogen storage disease II due to a mutation of the enzyme alpha-14-glucosidase.